Showing results (21-30 of 91) with videos related to
Sort By:
Pageof 10
British Journal of Cancer|January 1, 1993
Immunomodulation during prolonged treatment with combined interleukin-2 and interferon-alpha in patients with advanced malignancyA von Rohr, A K Ghosh, N Thatcher, et al.Best Practice & Research. Clinical Obstetrics & Gynaecology|September 21, 2001
The role of human papillomavirus vaccines in cervical neoplasiaP L Stern, R Faulkner, E C Veranes, et al.Experimental Cell Biology|January 1, 1986
Murine lymphocyte and embryonal carcinoma cell surface antigens recognised by rabbit anti-murine embryonal carcinoma serumP L Stern, N A Beresford, S M Bell, et al.Cancer Research|July 15, 1992
HLA class II antigen expression in human papillomavirus-associated cervical cancerS S Glew, M Duggan-Keen, T Cabrera, et al.Journal of Embryology and Experimental Morphology|February 1, 1981
Expression of Forssman antigen in the post-implantation mouse embryoM G Stinnakre, M J Evans, K R Willison, et al.Frontiers in Bioscience : a Journal and Virtual Library|December 4, 1998
Papillomavirus vaccinesM F Duggan-Keen, M D Brown, S N Stacey, et al.The Journal of Biological Chemistry|January 5, 2000
The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathwayK Webster, J Parish, M Pandya, et al.Journal of Immunogenetics|April 1, 1986
Murine embryonal carcinoma cells express class I MHC-like antigensP L Stern, N Beresford, S M Bell, et al.Cancer Immunology, Immunotherapy : CII|February 1, 1994
Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activityC Scheid, R Young, R McDermott, et al.Journal of Reproductive Immunology|November 1, 1987
Monoclonal antibody GB17 recognizes human syncytiotrophoblastB L Hsi, C J Yeh, P M Johnson, et al.Pageof 10